‌

US Patent 11746119 Cardiopathy-reducing phosphodiester lipids

Patent 11746119 was granted and assigned to Signpath Pharma on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Signpath Pharma

Current Assignee

Signpath Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11746119

Patent Inventor Names

John Kallikat Augustine

James McChesney

Annie Bouchard

Saravanan Kappusamy

Daniel Emil Levy

Date of Patent

September 5, 2023

Patent Application Number

17520287

Date Filed

November 5, 2021

Patent Citations

‌

US Patent 10975111 Cardiopathy-reducing phosphodiester lipids

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11746119 Cardiopathy-reducing phosphodiester lipids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API